[go: up one dir, main page]

Solomon, 2006 - Google Patents

Peptide Vaccine for Alzheimer's Disease

Solomon, 2006

Document ID
2003524572449249914
Author
Solomon B
Publication year
Publication venue
Handbook of Biologically Active Peptides

External Links

Snippet

The pathology of Alzheimer's disease (AD) shows a significant correlation between β- amyloid peptide (AβP) deposition and severity of dementia. We have shown that antibodies toward the N-terminal region of β-amyloid peptide suppress in vitro and in vivo formation of …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Similar Documents

Publication Publication Date Title
JP4804690B2 (en) Chimeric peptide as immunogen, antibody thereto, and immunization using chimeric peptide or antibody
Wisniewski et al. Immunotherapy for Alzheimer's disease
JP5362164B2 (en) Prevention and treatment of Alzheimer's disease
US6703015B1 (en) Filamentous bacteriophage displaying an β-amyloid epitope
ES2714692T3 (en) Tauopathies treatment
US6919075B1 (en) Bacteriophage displaying aβ epitopes and method of use
AU2006326283B2 (en) Therapeutic vaccine
EP1432441B1 (en) Use of hmgb1 for the activation of dendritic cells
Solomon Alzheimer's disease and immunotherapy
JP5722770B2 (en) Vaccine against amyloid folding intermediate
JP2003534351A (en) Synthetic, immunogenic but non-amyloidogenic peptide homologous to amyloid β for inducing an immune response to amyloid β and amyloid deposits
KR20070042566A (en) Prevention and treatment of synuclein and amyloidogenic diseases
AU2002341266A1 (en) Use of HMGB1 for the activation of dendritic cells
UA123390C2 (en) THERAPY AND DIAGNOSIS BASED ON PROTEIN-MEDIATED PATHOLOGY IN ALZGEIMER'S DISEASE
Solomon Immunological approaches as therapy for Alzheimer’s disease
DE60217107T2 (en) MULTANTIGENIC PEPTIDE CONTAINED MULTIPLE COPIES OF EPITOPES FROM A DEPOSIT POLYPEPTIDE AND ITS USE
Solomon et al. Immunotherapy for Alzheimer’s disease
Solomon Active immunization against Alzheimer's β-amyloid peptide using phage display technology
Solomon Peptide Vaccine for Alzheimer's Disease
Frenkel et al. Generation of anti-β-amyloid antibodies via phage display technology
EP1752472A2 (en) Chimeric amyloid beta peptides
Solomon Alzheimer's disease immunotherapy: from in vitro amyloid immunomodulation to in vivo vaccination
Schroeder Tau-Directed Immunotherapy for Alzheimer's Disease
HK1100328A (en) Chimeric amyloid beta peptides
MX2008007149A (en) Therapeutic vaccine